Woodline Partners’s Tectonic Therapeutic TECX Stock Holding History

Woodline Partners’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.44M	Hold	100,000	–	–	0.01%	771
2026 Q1	$3.09M	Sell	100,000 -100,000	-50%	-$2.46M	0.01%	746
2025 Q4	$4.17M	Hold	200,000	–	–	0.02%	665
2025 Q3	$3.14M	Sell	200,000 -121,637	-38%	-$2.51M	0.01%	659
2025 Q2	$6.39M	Buy	321,637 +19,422	+6%	+$394K	0.03%	515
2025 Q1	$5.35M	Buy	302,215 +172,106	+132%	+$5.61M	0.03%	491
2024 Q4	$6.01M	Buy	130,109 +64,661	+99%	+$2.73M	0.04%	449
2024 Q3	$1.98M	Buy	+65,448	New	+$1.2M	0.02%	478
2020 Q1	–	Sell	-15,992	Closed	-$3.86M	–	176
2019 Q4	$3.86M	Buy	+15,992	New	+$3.08M	0.16%	98

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Woodline Partners's TECX Position: Q2 2026 in Review

Woodline Partners held its Tectonic Therapeutic (TECX) position steady in Q2 2026 at 100,000 shares worth $3.44M. The position accounts for 0.01% of the portfolio, ranked #771.

Woodline Partners first reported a position in TECX in Q4 2019 and has held it in 9 quarters since. The position peaked at $6.39M in Q2 2025. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

Woodline Partners held 100,000 shares of Tectonic Therapeutic worth $3.44M as of Q2 2026.
Woodline Partners left its Tectonic Therapeutic share count unchanged in Q2 2026.
Tectonic Therapeutic made up 0.01% of Woodline Partners's portfolio in Q2 2026, its #771 holding.
Woodline Partners first reported a position in Tectonic Therapeutic in Q4 2019 and has held it in 9 quarters since.
Woodline Partners's Tectonic Therapeutic position peaked at $6.39M in Q2 2025.
123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.